| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,396 |
1,365 |
$131K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
878 |
855 |
$122K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,780 |
1,747 |
$108K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
869 |
845 |
$83K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,096 |
1,027 |
$57K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
659 |
646 |
$47K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
306 |
304 |
$20K |
| 87480 |
|
125 |
122 |
$7K |
| 87660 |
|
126 |
123 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
220 |
204 |
$5K |
| 87510 |
|
82 |
80 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
55 |
51 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
29 |
27 |
$2K |
| 76830 |
Ultrasound, transvaginal |
29 |
28 |
$2K |
| 86780 |
|
43 |
39 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
14 |
14 |
$1K |
| 86803 |
|
12 |
12 |
$941.92 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
15 |
15 |
$581.70 |
| 87340 |
|
13 |
13 |
$581.30 |
| 86850 |
|
12 |
12 |
$396.51 |
| 86901 |
|
12 |
12 |
$189.15 |
| 86900 |
|
12 |
12 |
$183.75 |
| 81025 |
|
26 |
25 |
$136.65 |
| 3078F |
|
91 |
84 |
$0.68 |
| 1036F |
|
56 |
55 |
$0.36 |
| 4004F |
|
32 |
30 |
$0.31 |
| 3074F |
|
17 |
16 |
$0.01 |